An intranasal quadruple variant vaccine approach using SARS-CoV-2 and influenza A: Delta, Omicron, H1N1and H3N2.

Saved in:
Bibliographic Details
Title: An intranasal quadruple variant vaccine approach using SARS-CoV-2 and influenza A: Delta, Omicron, H1N1and H3N2.
Authors: Singh, Revanth1 (AUTHOR), Gulani, Mahek1 (AUTHOR), Vijayanand, Sharon1 (AUTHOR), Arte, Tanisha1 (AUTHOR), Adediran, Emmanuel1 (AUTHOR), Pasupuleti, Dedeepya1 (AUTHOR), Patel, Parth1 (AUTHOR), Ferguson, Amarae1 (AUTHOR), Uddin, Mohammad1 (AUTHOR), Zughaier, Susu M.2 (AUTHOR), D'souza, Martin J.1 (AUTHOR) dsouza_mj@mercer.edu
Source: International Journal of Pharmaceutics. Oct2025, Vol. 683, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:03785173
DOI:10.1016/j.ijpharm.2025.126043